LatchBio

LatchBio

Cloud platform for biotech data management

About LatchBio

Simplify's Rating
Why LatchBio is rated
C+
Rated C on Competitive Edge
Rated B on Growth Potential
Rated C on Rating Differentiation

Industries

Data & Analytics

Biotechnology

Company Size

11-50

Company Stage

Series A

Total Funding

$32.1M

Headquarters

San Francisco, California

Founded

2021

Overview

Latch.bio offers a cloud-based platform for biotech companies to manage and analyze their data. It allows users to store unlimited raw data, enhancing collaboration and making data analysis faster and more accessible. The platform stands out by providing customizable data management without extensive infrastructure setup and ensuring high-level security for data processing. Latch.bio's goal is to help biotech firms accelerate their research and development milestones while reducing costs.

📈
Significant Headcount Growth
Simplify Jobs

Simplify's Take

What believers are saying

  • Increased adoption of cloud-native technologies boosts demand for LatchBio's scalable solutions.
  • The rise of personalized medicine aligns with LatchBio's robust data analysis capabilities.
  • AI integration in drug discovery creates opportunities for LatchBio's supportive infrastructure.

What critics are saying

  • Competition from DNAnexus and Seven Bridges may erode LatchBio's market share.
  • Rapid tech advancements require constant updates, straining LatchBio's resources and profitability.
  • Reliance on GPU technology exposes LatchBio to supply chain issues and price fluctuations.

What makes LatchBio unique

  • LatchBio offers a code-free platform, simplifying data analysis for non-specialists.
  • The platform provides unlimited data storage, eliminating silos and enhancing collaboration.
  • LatchBio's customizable platform allows biotech firms control over data without infrastructure setup costs.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$32.1M

Above

Industry Average

Funded Over

2 Rounds

Series A funding typically happens when a startup has a product and some customers, and now needs funding to scale. This money is usually used to grow the team, expand marketing, and improve the product. Venture capital firms are frequently the main investors here.
Series A Funding Comparison
Above Average

Industry standards

$15M
$8.2M
Discord
$15M
Canva
$28M
LatchBio
$100M
GitHub

Benefits

Competitive salary

Equity

Medical, dental, & vision insurance

Growth & Insights and Company News

Headcount

6 month growth

↑ 4%

1 year growth

↑ 4%

2 year growth

↑ 0%
Latch
Nov 6th, 2024
Why bioinformatics code will run on GPUs

As a first case-study, LatchBio, Inc. is releasing an accelerated version of nf-core/methylseq that uses the GPU aligner Arioc developed by Richard Wilton.

Vial
Oct 27th, 2023
How is the LatchBio Platform Helping Clinical Researchers Overcome Bottlenecks?

Having already raised over US$28 million, LatchBio is making waves in the world of data management and clinical research; read on to learn more about the company's innovative solutions and how they are helping researchers overcome common bottlenecks!

Forbes
Mar 27th, 2023
Meet The Three Berkeley Dropouts Empowering Biotechs With Code-Free Cloud-Based Biocomputing

LatchBio founders: Alfredo Andere, Kenny Workman, and Kyle Giffin. LatchBioMost industries today are experiencing an unprecedented data deluge – and synthetic biology is no exception. Twenty years ago, a typical biological experiment generated 3-5 megabytes of information. Today, a routine synthetic biology workflow produces anywhere from 1,000 to 40,000 terabytes. That is a billion times more data! Such a large number of data points is simply impossible to interpret by human eye. This is why almost every bio lab today has to set up custom bioinformatics pipelines, invest in cloud computing, and master advanced data visualization software – all that just to see the results of their experiments.A San Francisco startup, LatchBio, hopes to make data analysis much easier for biologists with its full-stack biocomputing infrastructure

TechCrunch
Jun 2nd, 2022
Latchbio Empowers Scientists With A Code-Free Platform For Handling Big Biotech Data

Biologists and other scientists are confronted these days with a deep sea of data and a bewildering panoply of tools to apply to it — many of which require a specialist to operate. Hiring one is a challenge and farming out the work may take months … but LatchBio offers an option that can have []

Business Wire
Jun 2nd, 2022
Latchbio Raises $28M Series A To Bring A Modern Data Analysis Stack To Biologists

SAN FRANCISCO--(BUSINESS WIRE)-- #AI--LatchBio raises $28M Series A to bring modern data analysis stack to biologists

Recently Posted Jobs

Sign up to get curated job recommendations

LatchBio is Hiring for 0 Jobs on Simplify!

Find jobs on Simplify and start your career today

💡
We update LatchBio's jobs every 8 hours, so check again soon! Browse all jobs →